Clinical Features of Very Early-onset Inflammatory Bowel Disease in Japan: a Retrospective Single-center Study
Overview
Authors
Affiliations
Background/aims: Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in patients younger than 6 years, is a challenge for pediatric gastroenterologists. Although there have been reports regarding VEO-IBD in Western countries, those in Asia are still lacking. This study aimed to investigate the clinical features of Japanese VEO-IBD patients.
Methods: Patients with VEO-IBD diagnosed between 2006 and 2019 were evaluated retrospectively. The disease phenotypes were classified into ulcerative colitis type (UC-type) and Crohn's disease type (CD-type), and the clinical features and courses were compared between the phenotypes.
Results: Overall, 54 VEO-IBD patients (19 patients with UC-type and 35 patients with CD-type) were evaluated. The median age at onset was 18 months. One patient had severe combined immunodeficiency (SCID), and 9 patients had monogenic IBD. Monogenic IBD was more prevalent in the CD-type patients with perianal disease (CD-type (PD)). The age at onset was significantly lower in the CD-type group (P<0.05). The most common initial symptom was bloody stools (70%), followed by diarrhea (63%), weight loss (24%), fever (20%), and perianal disease (20%). Excluding patients with SCID and monogenic IBD, 23 out of 44 patients (52%) required biologics. The biologics were switched in 11 out of 44 patients (25%), and the majority of these patients (82%) were in the CD-type group. Overall, 9 patients (20%) required intestinal resection or ostomy placement.
Conclusions: CD-type tends to occur at an earlier age, and monogenic IBD occurs significantly more frequently in CD-type (PD). Disease severity and treatment should be individualized, owing to the disease heterogeneity.
Lee W, Chew K, Huang J, Tanpowpong P, Mercado K, Reodica A Front Pediatr. 2025; 13:1487253.
PMID: 40051907 PMC: 11882516. DOI: 10.3389/fped.2025.1487253.
Eslamian G, Jamee M, Momen T, Rohani P, Ebrahimi S, Mesdaghi M Clin Exp Immunol. 2024; 217(1):1-11.
PMID: 38651248 PMC: 11188541. DOI: 10.1093/cei/uxae037.
Fumita T, Terui K, Shibata R, Takenouchi A, Komatsu S, Oita S Pediatr Surg Int. 2024; 40(1):73.
PMID: 38451357 PMC: 10920427. DOI: 10.1007/s00383-024-05662-8.
Lee Y, Kim E, Choi S, Jang H, Kim Y, Choi S Gut Liver. 2023; 18(3):498-508.
PMID: 38013474 PMC: 11096907. DOI: 10.5009/gnl230022.